Objective: to investigate the safety of low molecular weight heparin to prevent deep venous thrombosis after primary hip replacement surgery.
目的：研究人工髋关节置换术后使用低分子肝素预防深静脉血栓的安全性。
Conclusion The low molecular weight heparin is safe and effective in preventing postoperative deep vein thrombosis in patients following hip and knee surgery.
结论低分子肝素能安全、有效地预防髋膝关节术后深静脉血栓形成。
The characteristics in the molecular biology and its application in reconstructive surgery of the hip was reviewed.
作者综述了OP - 1的分子生物学特性及其在髋关节重建术中的应用。
Objective to evaluate the efficacy and safety of low molecular weight heparin (LMWH) in prophylaxis of postoperative deep vein thrombosis (DVT) following hip and knee surgery.
目的评价低分子肝素预防髋、膝关节术后深静脉血栓形成(DVT)的疗效和安全性。
ObjectiveProphylactic use of low molecular weight heparin in orthopedic surgery is safe and effective anticoagulant therapy reduced the incidence of deep vein thrombosis rate.
目的探讨低分子肝素预防骨科术后深静脉血栓形成的疗效及安全性。
ObjectiveProphylactic use of low molecular weight heparin in orthopedic surgery is safe and effective anticoagulant therapy reduced the incidence of deep vein thrombosis rate.
目的探讨低分子肝素预防骨科术后深静脉血栓形成的疗效及安全性。
应用推荐